Can the CBD Industry Survive Without Global Regulatory Harmony?
The CBD market has grown from a niche wellness trend to a multibillion-dollar global industry in under a decade. Yet for all its commercial momentum, it remains hindered by a complex and often contradictory regulatory environment. While some countries have legalised or tolerated cannabidiol under specific conditions, others maintain restrictive or ambiguous policies. In the absence of clear, coordinated frameworks, the question arises: can the CBD industry sustain its growth without global regulatory harmony?
A Patchwork of Policies
Around the world, the legal status of CBD varies dramatically. In the United States, hemp-derived CBD is legal at the federal level under the 2018 Farm Bill, provided it contains less than 0.3% THC. However, the FDA has yet to formalise its stance on the use of CBD in food and dietary supplements, leaving a significant regulatory gap that individual states have tried to fill, with varying results.
In Europe, despite the European Commission’s decision to treat CBD as a novel food, implementation differs from country to country. France, Germany, and the Netherlands have adopted relatively permissive stances, while others impose stricter limits or operate under unclear rules. Countries such as Japan and South Korea allow CBD products but maintain tight restrictions on trace THC content, while major markets like China and Russia maintain outright bans.
This regulatory fragmentation complicates international trade, consumer access, and innovation, and creates an uneven playing field for companies operating across borders.
The Role of Industry Ethics and Accountability
In the face of regulatory uncertainty, some CBD brands have voluntarily adopted strict internal standards to guide their operations. For example, Mama Kana in the USA has positioned itself as a company that prioritises transparency and responsible practices. Rather than wait for formalised global rules, the brand has chosen to implement rigorous quality controls and clear product labelling from sourcing to distribution.
Mama Kana’s approach reflects a growing awareness within the industry: trust must be earned, especially in a space where consumers are often left to navigate confusing legal messages. The brand’s commitment to lab-tested products and accessible information is not simply a strategic move, it’s a necessary response to an inconsistent market environment. By focusing on traceability and reliability, Mama Kana contributes to building a more credible and sustainable CBD ecosystem.
The Importance of Regulatory Harmonisation
The lack of unified global standards presents several challenges. First, it hinders cross-border commerce, making it difficult for CBD producers to expand into new markets without navigating a tangle of compliance requirements. This has a direct impact on pricing, availability, and the ability of smaller businesses to compete internationally.
Second, it creates risk for consumers. In countries with weak or nonexistent oversight, the market is vulnerable to misleading labels, poor-quality products, and even health hazards. A harmonised regulatory system would not only protect consumers but also support scientific research, investment, and clearer public health communication.
Third, disjointed regulations discourage innovation. Companies must divert significant resources into legal compliance and risk management, rather than research and development or product improvement. This stifles progress in a field that has significant potential for medical and therapeutic advancement.
Moving Forward: Is Global Consensus Realistic?
Achieving global regulatory harmony for CBD is a complex task, complicated by political, cultural, and economic differences between countries. However, steps in the right direction have already been taken. International bodies such as the World Health Organization have acknowledged the therapeutic potential of CBD and called for more consistent regulation. Some trade alliances and regional bodies have also begun to explore frameworks for cross-border regulation.
In the meantime, the industry must continue to self-regulate, establishing best practices that prioritise consumer safety, environmental responsibility, and product integrity. Brands that invest in long-term trust and accountability are laying the foundation for what a future harmonised market could look like.
Without a unified regulatory framework, the CBD industry may never reach its full global potential. But with a combination of ethical business practices, scientific advocacy, and gradual legal progress, it may continue to grow in a responsible and resilient way, even in the face of legal fragmentation.
